Skip to content
lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
PRM Pharma, LLC
New 2026 ACC Expert Consensus Decision Pathway and 2025 AHA/ACC Hypertension Guideline Support the Role of Chlorthalidone in Resistant Hypertension
November 5, 2026
PRM Pharma and Ingenus Pharmaceuticals Announce Orange Book Listing of Patent Protecting HemiClor® Formulation Technology
October 5, 2026
PRM Pharma and Ingenus Pharmaceuticals Announce Orange Book Listing of Patent Protecting HemiClor® Formulation Technology
July 28, 2026